|
References
|
1
|
Becker, D.V., Hurler, J.R., Motazedi, A., et al. Ablation of postsurgical thyroid remnants in patients with differentiated thyroid cancer can be achieved with less whole body radiation”, J Nucl Med, vol. 23, pp. 43, 1982. Volver
|
|
2
|
Sgouros, G.; Chiu, S.; Pentlow, K.S.; Brewster, L.J.; Kalaigian, H.; Baldwin, B.; Daghignian, F.; Graham, M.C.; Larson, S.M.; Mohan, R. Three-Dimensional Dosimetry for Radioimmunotherapy Treatment Planning. J Nucl Med, 34:1595-1601, 1993. Volver
|
|
3
|
Kolbert, K.S.; Sgouros, G.; Scott, A.M.; Bronstein, J.E.; Malane, R.A.; Zhang, J.; et al. Implementation and Evaluation of Patient-Specific Three-Dimensional Internal Dosimetry. J Nucl Med, 38:301-308, 1997. Volver
|
|
4
|
Lima, F.F., Stabin, M., Khoury, H.J. Volume and Activity Concentration Estimation in Phantom of Thyroid Tissue Remnants Using SPECT – Radioprotecção, 2(4 e 5):44-53, Dec/2003 a May/2004. Volver
|
|
5
|
Yoriyaz, H.; Stabin, M.G.; Santos, A. Monte Carlo MCNP-4B-Based Absorbed Dose Distribution Estimates for Patient-Specifc Dosimetry. J Nucl Med, 42:662-669, 2001. Volver
|
|
6
|
Loevinger, R.; Budinger, T.F.; Watson, E.E. in collaboration with MIRD Committee. MIRD PRIMER for absorbed dose calculation, 1991, p. 1-17. Volver
|
|
7
|
Furhang, E.E.; Larson, S.M.; Buranopong, P.; Humm, J.L. Thyroid Cancer Dosimetry Using Clearance Fitting. J Nucl Med, 40:131-136, 1999.
|
|
8
|
Maxon, H.R.; Thomas, S.R.; Hertzberg, V.S.; Kereiakes, J.G.; Chen, I-W.; Sperling, M.I.; Saenger, E.L. Relation between effective radiation dose and outcome of radioiodine therapy for thyroid cancer. N Engl J Med, 309(16):937, 1983. Volver
|
|
9
|
Degroot, L.J.; Reilly, M. Comparasion of 30- and 50 mCi dose of iodine-131 for thyroid ablation. Annais Int Med, 96:51-53,1982. Volver
|
|
10
|
Rodríguez, J.R.R. Tratamiento quirúrgico y tratamento complementario com radioyodo 131I. Rev Espan Med Nucl, suplemento 1:28-36, 1989. Volver
|
|
11
|
Maxon, H.R. The role of 131I in the treatment of thyroid cancer. Thyroid Today, 16(2):1, 1993. Volver
|
|
12
|
Harbert, J.C. Radioiodine Therapy of Differentiated Thyroid Carcinoma. In: Nuclear Medicine Diagnosis and Therapy. Ed. Thieme, New York, 1996. Cap. 40, p. 951-973. Volver
|
|
13
|
Goolden, A.W.; Davey, J.B. The ablation of normal thyroid tissue with iodine 131. British J Radiol, 36(425): 340-345, 1962 Volver
|
|
14
|
Comtois, R.; Thériault, C.; del Vecchio, P. Assessment of the efficacy of iodine-131 for thyroid ablation. J Nucl Med, 34: 1927-1930,1993. Volver
|
|
15
|
Mortelmans, L.; Nuyts, J.; van Pamel, G.; van den Maegdenbergh, V.; de Roo, M.; Suetens, P. A New Thresholding Method for Volume Determination by SPECT. Eur J Nucl Med, 12:284-290, 1986. Volver
|
|
16
|
Thomas, S.R.; Maxon, H.R.; Kereiakes, J.G.; et al. Quantitative external couting enabling improved diagnostic and therapeutic decision in patients with well-differenciated thyroid cancer. Radiology, 122:731, 1977. Volver
|
|
17
|
Traino AC, Martino FDi, Lazzeri M, Stabin MG. Influence of thyroid volume reduction on calculated dose in radioiodine therapy of Graves'hyperthyroidism. Phys Med Biol. 45:121-129, 2000. Volver
|
|
|
